Skip to main content

and
  1. No Access

    Article

    Determination of 5-azacitidine in human plasma by LC–MS/MS: application to pharmacokinetics pilot study in MDS/AML patients

    Azacitidine (Vidaza®, AZA) is a mainstay for treating acute myeloid leukemia (AML) in patients unfit for standard induction and other myelodysplastic syndromes (MDS). However, only half of the patients usually...

    Melanie Donnette, Loic Osanno, Madeleine Giocanti in Cancer Chemotherapy and Pharmacology (2023)

  2. Article

    Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue

    Specificities of COVID-19 disease course in patients with haematologic malignancies are still poorly studied. So, we aimed to compare patients with haematologic malignancies to patients without malignancies, m...

    Robin Arcani, Julien Colle, Raphaël Cauchois, Marie Koubi in Annals of Hematology (2021)